Company
Every investor coverage indicates participated in a round Harvard raised.
Companies Harvard acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
Stories naming Harvard. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Profiles seven early-stage agtech ventures at Beanstalk's Drought Venture Studio, a program backed by the Future Drought Fund, each developing tools to help farmers withstand drought.
Profile of scientist-entrepreneur Andrew Wilks covering the GSK sale of his cancer molecule, his SYNthesis BioVentures fund's family-office backers, and portfolio plays including Aculeus Therapeutics.
Scalare Partners announces an investment in Circadian Health Innovations, whose wearable device guides healthier light habits, and two board additions.
Twelve startups, eleven American and one Australian, will join the newest cohort of Techstars' thirteen-week aerospace program, run alongside two US space bodies.
AfterWork Ventures explains why it invested pre-seed in Samphire Neuroscience, a neurotech startup whose headband eases menstrual symptoms, alongside hardware accelerator HAX, profiling the Oxford-founded team and the women's health opportunity.
Also Startup Daily
Republished AFR report recalls Go1's earlier backing and Series C investors, including OIF, while its reported Series D at a billion-dollar valuation remains in progress and a listing is flagged.
Also SmartCompany·SmartCompany